Eurofins Scientific Drops 4.16% Despite Solid 2025 Results and Raised Targets
Eurofins Scientific's stock fell by 4.16% on Thursday, closing at €67.68 down from €70.62 the previous day. This decline occurred on the same day the company announced solid preliminary results for 2025, featuring a 24% increase in earnings per share to €2.31 and an organic growth of 4.1%. Concurrently, the group increased its dividend by 20% to €0.72 per share.
Substantial Profitability Improvement
Eurofins Scientific has shown a substantial improvement in profitability for the past fiscal year. Earnings per share increased by 24% to €2.31, reflecting a favorable operational momentum. The organic growth of 4.1% indicates a sustained expansion of the group's activities in a measured market environment. In terms of shareholder distribution, the group has strengthened its dividend policy by increasing it by 20%, raising it to €0.72 per share, signaling increased confidence in its cash flow generation trajectory.
Divergent Analyst Recommendations
Analyst recommendations vary on the medium-term outlook. Kepler Cheuvreux has raised its price target from €72.00 to €81.00, implying an upside potential of 19.6% from the current price. Meanwhile, Morgan Stanley maintains its 'market weight' stance while modestly raising its target from €61.00 to €64.00, representing a limited potential of 5.5%. This divergence in opinion between the two firms reflects nuanced views on the valuation of the stock following the announcement of its annual results.
